Home›Insurance›Liability Insurance›Court revives over 500 Tylenol private lawsuits agains…

Court revives over 500 Tylenol private lawsuits against Kenvue

The 2nd U.S. Circuit Court of Appeals said a lower court improperly excluded parents’ expert testimony tying prenatal Tylenol to autism-related diagnoses.

Reported · Written up by our desk · Liability Insurance

A federal appeals court in Manhattan on July 13 revived more than 500 private lawsuits against Kenvue, the maker of Tylenol, over allegations that prenatal use during pregnancy is linked to autism and attention deficit hyperactivity disorder in children, according to Insurance Journal.

The 2nd U.S. Circuit Court of Appeals said a district court judge improperly excluded testimony from expert witnesses offered by parents and guardians who argued that Tylenol use during pregnancy contributed to those conditions. The outlet noted there is no firm scientific evidence supporting a link.

Insurance Journal also reported that the issue drew renewed attention after President Donald Trump and top U.S. health officials suggested in September that there could be a connection between Tylenol and autism. Kenvue did not immediately respond to a request for comment.

Kenvue has said acetaminophen, Tylenol’s active ingredient, is safe and that doctors and medical societies consider it the preferred way to treat pain and fever during pregnancy. The story added that Kenvue’s shares were down during morning trading, and that Monday’s decision followed Kenvue’s November agreement to be acquired by Kimberly-Clark for more than $40 billion.

Sources